Skip to main content
Signal8

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) AI Dilution Summary

Updated Nov 13, 2026

Cash was $17,458,418 at 2026-09-30, against estimated monthly burn of $900,117. The company's funding channel is an active ATM program with B. Riley Securities, Inc. and A.G.P./Alliance Global Partners, authorised to $50,000,000. Since the program began, 721,645 shares have been sold through 2026-11-13.